Invesco NASDAQ Biotechnology ETF
IBBQ
35 hedge funds and large institutions have $16.7M invested in Invesco NASDAQ Biotechnology ETF in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 11 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
6.73% less ownership
Funds ownership: 29.66% → 22.93% (-6.7%)
13% less funds holding
Funds holding: 40 → 35 (-5)
23% less capital invested
Capital invested by funds: $21.7M → $16.7M (-$4.97M)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CFA
Churchill Financial Advisors
Louisville,
Kentucky
|
+$603K |
| 2 |
LW
Lauer Wealth
Valparaiso,
Indiana
|
+$184K |
| 3 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$179K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$118K |
| 5 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
+$92.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$4.02M |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$1.78M |
| 3 |
Jane Street
New York
|
-$939K |
| 4 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
-$576K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$535K |
IBBQ Hedge Fund Activity: Q2 2026 in Review
35 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q2 2026, worth a combined $16.7M — down 23% from $21.7M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of IBBQ and 6 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 12 added.
The largest buyer was Churchill Financial Advisors, opening a new position worth an estimated $603K. The largest seller was LPL Financial, cutting an estimated $4.02M.
- 35 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q2 2026, down from 40 in Q1 2026.
- Funds reported $16.7M of Invesco NASDAQ Biotechnology ETF stock for Q2 2026, down 23% quarter-over-quarter.
- 6 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q2 2026 and 11 closed out, a net change of -5 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q2 2026 was Churchill Financial Advisors, an estimated $603K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q2 2026 was LPL Financial, an estimated $4.02M sold.
Based on aggregated 13F filings for Q2 2026.